Overview
What is Biocon Inc?
Biocon Inc, headquartered in Edison, New Jersey, serves as the primary entity responsible for supporting the tax-exempt mission of the Musculoskeletal Transplant Foundation Inc. (MTF). As a holding company, Biocon holds the majority stake in both MTF, a U.S.-based nonprofit organization, and Deutsches Institut Fur Zell-Und Gewebeersatz GMBH (DIZG), a German nonprofit organization. Biocon's primary function is to safeguard and manage real estate assets utilized by MTF. The Musculoskeletal Transplant Foundation's mission revolves around providing top-quality allograft tissues for transplantation, research, and education. DIZG, on the other hand, specializes in the cultivation and distribution of various tissues, including keratinocytes and musculoskeletal tissue. Biocon holds decision-making authority over essential changes within MTF and DIZG, such as mergers and dissolutions, and is responsible for electing or appointing their respective board members. Biocon continues to oversee and guide the activities of both organizations, ensuring their alignment with the provision of high-quality human allografts.
Is Biocon Inc legitimate?
Biocon Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Biocon Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Biocon Inc?
Biocon Inc, acting as the holding company for the Musculoskeletal Transplant Foundation Inc. (MTF) and Deutsches Institut fur Zell- und Gewebeersatz GmbH (DIZG), supports their respective missions. MTF, a non-profit organization, focuses on providing high-quality allograft tissues for transplantation, research, and education. DIZG specializes in culturing and distributing various tissue forms, including keratinocytes and musculoskeletal tissues. Biocon Inc has the authority to approve fundamental amendments to the organizational documents of MTF and DIZG, as well as certain corporate transactions. Additionally, Biocon Inc has the exclusive right to elect or appoint all members of the boards of directors for MTF and DIZG. Biocon Inc continues to monitor and guide the activities of both organizations, as well as any affiliates that may be formed or acquired in the future, to foster the provision of high-quality human allografts.
Who is the CEO of Biocon Inc?
Joseph A Yaccarino is the President/Ce of Biocon Inc.
What is the revenue of Biocon Inc?
Biocon Inc's revenue in 2022 was $3,214,643.
Who are the executives of Biocon Inc and what are their salaries?
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $804,340
- Other: $49,435
- Compensation: $0
- Related: $637,326
- Other: $40,589
- Compensation: $0
- Related: $464,478
- Other: $49,435
- Compensation: $0
- Related: $75,000
- Other: $0
- Compensation: $0
- Related: $35,000
- Other: $0
- Compensation: $0
- Related: $32,500
- Other: $0
- Compensation: $0
- Related: $27,500
- Other: $0
- Compensation: $0
- Related: $27,500
- Other: $0
- Compensation: $0
- Related: $25,000
- Other: $0
- Compensation: $0
- Related: $25,000
- Other: $0
- Compensation: $0
- Related: $22,500
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for Biocon Inc?
Biocon Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Mission Statement of Biocon Inc
Biocon Inc, acting as a holding company, supports the tax-exempt mission of the Musculoskeletal Transplant Foundation Inc. (MTF). Biocon's role is significant as it serves as the sole voting member of MTF, a non-profit organization dedicated to providing high-quality allograft tissues for transplantation, research, and education. In addition, Biocon has authority to approve fundamental amendments to MTF's organizational documents and certain corporate transactions such as mergers and dissolutions. Furthermore, Biocon holds the exclusive right to elect or appoint all members of MTF's board of directors. Deutsche Instut für Zell- und Gewebesatz GmbH (DIZG), a German non-profit organization, is another entity supported by Biocon. DIZG specializes in culturing and distributing keratinocytes, musculoskeletal, and other tissue forms. Biocon continuously monitors and guides the activities of both MTF and DIZG, as well as any affiliates that may be formed or acquired in the future, to foster the provision of high-quality human allografts.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Biocon Inc plays a crucial role in supporting the Musculoskeletal Transplant Foundation Inc. (MTF) by serving as its sole voting member and holding company, ensuring alignment with its mission to provide quality allograft tissues for transplantation, research, and education. By safeguarding the real property assets utilized by MTF and overseeing significant organizational decisions, Biocon Inc enhances the operational stability and strategic direction of MTF.
Furthermore, Biocon Inc reflects its commitment to advancing health care through its complementary relationship with Deutsches Institut Fur Zell-und Gewebeersatz GmbH (DIZG), which specializes in the culturing and distribution of various tissues. This partnership broadens the scope of services and innovations available in tissue transplantation and research, ultimately benefiting patients in need of musculoskeletal and other tissue forms.
Through its governance and oversight, Biocon Inc not only bolsters the activities of MTF and DIZG but also promotes a collaborative environment conducive to advancing scientific research and improving clinical outcomes in regenerative medicine and transplantation. In essence, Biocon Inc's impact is felt through its vital support in the provision of high-quality human allografts, thereby playing an instrumental role in improving patient care and outcomes in the healthcare sector.
This information is meant to be a general summary of Biocon Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Program Service Revenue: $3,214,643
- Gross Receipts: $3,214,643
Assets and Liabilities:
- Total Assets: $16,971,976
- Total Liabilities: $12,984,371
- Net Assets: $3,987,605
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MAY ST MEDICAL -RENTAL INCOME
Revenue
$2,396,251
OLYPHANT - RENTAL INCOME
Revenue
$532,972
JESSUP - RENTAL INCOME
Revenue
$285,420
Organization Details
Founding Year
1998
Phone
(732) 661-0202Principal Officer
Joseph A Yaccarino
Main Address
125 MAY STREET, EDISON, NJ, 08837
NTEE Category
Code: E02 - Health
If you are a representative of Biocon Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.